Brought to you by 
Integrated Sciences to sell Molecular Detection's MRSA assay
30 Sep 2010
Executive Summary
Diagnostics start-up Molecular Detection Inc. has licensed Integrated Sciences Pty. Ltd. (clinical diagnostics and life science research products) exclusive rights to distribute in Australia its Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) assay.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Integrated Sciences to sell Molecular Detection's MRSA assay
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice